drugset / Trial / NCT04246190
A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics and safety of CKD-396.
Timeline
- Start
- 2020-02-24
- Primary completion
- 2020-04-10
- Completion
- 2020-07-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CKD-396 | Unknown | — | Oral |
| Subject | D759 | Unknown | — | Oral |
| Subject | Lobeglitazone | Small molecule | — | Oral |